About UsUnderstanding AMLInterviewsGlobal NetworkGet InvolvedStoriesResources

Are CAR T-cell treatments likely to become available for AML?

Gail Roboz

September 28, 2020

During Blood Cancer Awareness Month, Know AML spoke to Gail Roboz, a world-leading doctor in AML. We asked, "Is there any prospect of CAR T-cell immunotherapy treatments becoming available for AML?" In this video, Gail describes how CAR T-cells have proved to be a promising modality for other hematological malignancies, before describing their use in clinical trials in AML and the results so far.